| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/03/2001 | CA2386887A1 Encapsulated active material immobilized in hydrogel microbeads |
| 05/03/2001 | CA2386840A1 Medication retention assembly for oral delivery tray |
| 05/03/2001 | CA2385929A1 Use of gdnf for treating corneal defects |
| 05/02/2001 | EP1095660A2 Therapeutic combination containing terpinen-4-ol and medicinal plants |
| 05/02/2001 | EP1095651A2 Multipor food protection |
| 05/02/2001 | EP1095650A1 Double phase time-controlled release system |
| 05/02/2001 | EP1095162A1 Archiving of vectors |
| 05/02/2001 | EP1094889A1 Flowable preparations of the water-in-oil emulsion type having an increased water content |
| 05/02/2001 | EP1094888A1 Flowable preparations of the water-in-oil emulsion type having an increased water content |
| 05/02/2001 | EP1094862A1 Methods, systems, and kits for implanting articles |
| 05/02/2001 | EP1094842A1 Pharmaceutical compositions containing low-melting waxes |
| 05/02/2001 | EP1094841A1 Pharmaceutical levothyroxine preparation |
| 05/02/2001 | EP1094822A1 Water miscible macrolide solutions |
| 05/02/2001 | EP1094820A2 Use of bisphosphonates in the treatment of vascular restenosis |
| 05/02/2001 | EP1094819A1 Injectable sodium acetylsalicylate composition and method |
| 05/02/2001 | EP1094818A1 Use of tricyclic antidepressants for local analgesia |
| 05/02/2001 | EP1094802A1 Pharmaceutical composition for injection based on paracetamol |
| 05/02/2001 | EP1094799A1 Apomorphine-containing dosage forms for ameliorating male erectile dysfunction |
| 05/02/2001 | EP1094797A1 Transdermal plaster containing at least one active ingredient which influences blood serum lipid levels |
| 05/02/2001 | EP1094796A1 Topical plaster with non-steroidal antirheumatic agents with an acid group |
| 05/02/2001 | EP1094795A1 Therapeutic system with addition of nacreous pigments |
| 05/02/2001 | EP1094794A2 Dry-copying method for producing flat, individually dosed preparations of active agents |
| 05/02/2001 | EP1094793A1 Composition containing glycerol trinitrate, method for producing said composition and use of the same |
| 05/02/2001 | EP1094792A1 Materials and methods relating to encapsulation |
| 05/02/2001 | EP1094791A1 Thixotropic formulations for filling capsules |
| 05/02/2001 | EP1094790A1 Sustained release pharmaceutical preparation |
| 05/02/2001 | EP1094788A1 Croscarmellose taste masking |
| 05/02/2001 | EP1094786A1 Perfume compositions |
| 05/02/2001 | EP1094781A1 Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof |
| 05/02/2001 | EP0938318B1 Tablet with controlled release of alfuzosine chlorydrate |
| 05/02/2001 | CN1293576A Medicinal compositions adhering to stomach/duodenum |
| 05/02/2001 | CN1293574A Materials for preventing arteriosclerosis, Immunopotentiating meterials, vertegrates fed with these materials and eggs thereof |
| 05/02/2001 | CN1293571A Extended release tiagabine formulations with reduced side-effects |
| 05/02/2001 | CN1293568A Lipophilic microparticles containing protein drug or antigen and formulation comprising same |
| 05/02/2001 | CN1293553A Liquid polymeric compositions for controlled release of bioactive substances |
| 05/02/2001 | CN1293215A Polymer containing siloxane, its preparation method and use |
| 05/02/2001 | CN1293061A Process for preparing face beautifying medicines and its product |
| 05/02/2001 | CN1293050A Plaster |
| 05/02/2001 | CN1293035A Acupoint application of nm-material |
| 05/02/2001 | CN1065263C Film coating compositions and preparation method and usage thereof |
| 05/02/2001 | CN1065141C Pharmacuetical preparation for administration from nasal mucosa |
| 05/02/2001 | CN1065110C Colloidally disperson agent of active compount |
| 05/01/2001 | USRE37160 Synthesis of tyrosine derived diphenol monomers |
| 05/01/2001 | US6225521 Patch includes permeable structure completely embedded in matrix close to surface to modify overall adhesive power |
| 05/01/2001 | US6225448 1gG /transferrin receptor fusion protein |
| 05/01/2001 | US6225356 Cromolyn sodium containing composition and method of treatment for vilvar vestibulitis interstitial cystitis vukvar vaginitis and vaginitis dynea |
| 05/01/2001 | US6225354 Subjecting unsaponified beeswax to liquid extraction with liquid organic extractant in which primary aliphatic alcohols are soluble; recovering alcohol mixture and isolating alcohols |
| 05/01/2001 | US6225348 Contacting eye with prostaglandin f.sub.2.alpha. derivative for therapy of macular degeneration in an eye |
| 05/01/2001 | US6225343 Compositions and methods comprising morphine gluconate |
| 05/01/2001 | US6225327 Topically administering dihydropyridine compound which is human conjunctival mast cell stabilizer for alleviating ocular allergic reactions involving conjunctival mast cell degranulation |
| 05/01/2001 | US6225326 Administering insulin sensitivity enhancer in combination with an .alpha.-glucosidase inhibitor for therapy to reduce side effect for diabetic patient |
| 05/01/2001 | US6225304 Dry solid mixture of an amoxicillin and a hydroxy-polycarboxylic acid |
| 05/01/2001 | US6224939 Ejecting a solid matrix additive upwardly through a nozzle, additive descends into a free-fall condition, and is then encapsulated below its ejection point, solidification occurs while still in free-fall; taste masking |
| 05/01/2001 | US6224913 Surface treatment |
| 05/01/2001 | US6224912 Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment |
| 05/01/2001 | US6224911 Spray coating with anionic polymer containing methacrylic acid and acrylic ester units |
| 05/01/2001 | US6224910 Method for the preparation of an enteric coated high drug load pharmaceutical composition |
| 05/01/2001 | US6224909 Fast decomposing pellets |
| 05/01/2001 | US6224908 Oral delivery system |
| 05/01/2001 | US6224907 Anti-asthma therapy |
| 05/01/2001 | US6224906 St. John's wort composition |
| 05/01/2001 | US6224905 Porous matrix network |
| 05/01/2001 | US6224904 Compressed form |
| 05/01/2001 | US6224903 Hydrophilic-hydrophobic polymers |
| 05/01/2001 | US6224902 Mixture of delivery vehicle and sterol |
| 05/01/2001 | US6224901 Method for delivering beneficial compositions to hair follicles |
| 05/01/2001 | US6224900 Nicotine barrier layer of nitrile rubber and degradation agent |
| 05/01/2001 | US6224899 Adhesive cooling composition and process for its preparation |
| 05/01/2001 | US6224897 Applying transdermal nicotine patch |
| 05/01/2001 | US6224894 Medical equipment |
| 05/01/2001 | US6224893 Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering |
| 05/01/2001 | US6224887 Antifungal nail lacquer and method using same |
| 05/01/2001 | US6224857 Pharmaceutical preparations comprised of salts of hyaluronic acid with local anaesthetics |
| 05/01/2001 | US6224853 Aqueous compositions comprising a lipid and a lanolin-derived surfactant, and their use |
| 05/01/2001 | US6224850 Antiwrinkle cosmetic/pharmaceutical compositions comprising iridaceae extracts |
| 05/01/2001 | US6223455 Spray drying apparatus and methods of use |
| 05/01/2001 | CA2203464C Antimycotic ectoparasiticidal product - external use |
| 05/01/2001 | CA2186919C Therapeutic anti-inflammatory and analgesic pharmaceutical composition containing nimesulide 4-nitro, 2 phenoxyphenyl methane sulphonamide for use transdermally and a process for the manufacture thereof |
| 05/01/2001 | CA2150939C Stable protein: phospholipid compositions and methods |
| 05/01/2001 | CA2088376C Dosage form for time-varying patterns of drug delivery |
| 05/01/2001 | CA2048856C 15-deoxyspergualin suppository |
| 05/01/2001 | CA2034926C Treatment of poisoning and compositions for use therein |
| 04/26/2001 | WO2001029233A2 Chimeric immunogenic compositions and nucleic acids encoding them |
| 04/26/2001 | WO2001029189A2 Synthetic substrate for tissue formation |
| 04/26/2001 | WO2001029170A1 Protein-containing granules and granule formulations |
| 04/26/2001 | WO2001029061A1 Novel fusidic acid derivatives |
| 04/26/2001 | WO2001029046A2 A salt of morphine |
| 04/26/2001 | WO2001028918A1 Controlled release of doxorubicin |
| 04/26/2001 | WO2001028616A1 Medicament pack |
| 04/26/2001 | WO2001028603A1 Formulations for delivery of osteogenic proteins |
| 04/26/2001 | WO2001028602A1 Formulations of hyaluronic acid for delivery of osteogenic proteins |
| 04/26/2001 | WO2001028591A2 Injection vehicle for polymer-based formulations |
| 04/26/2001 | WO2001028590A2 PHARMACEUTICAL COMPOSITIONS CONTAINING N-[N-(3,3-DIMETHYLBUTYL)-1-α-ASPARTYL]-L-PHENYLALANINE METHYL ESTER |
| 04/26/2001 | WO2001028589A2 Shaped body comprising an amphiphilic outer phase and a lipophilic inner phase |
| 04/26/2001 | WO2001028587A2 Magnetic targeted carrier |
| 04/26/2001 | WO2001028571A1 Stable preparations for treating bedsore, skin ulcer and wound |
| 04/26/2001 | WO2001028570A2 Zinc lactate lozenges and uses thereof |
| 04/26/2001 | WO2001028564A1 Pharmaceutical compositions and preparations for treatment of metabolic bone disease |
| 04/26/2001 | WO2001028563A1 Ciclesonide-containing aqueous pharmaceutical composition |
| 04/26/2001 | WO2001028562A1 Ciclesonide contained pharmaceutical composition for application to mucosa |